Abstract

HUA HONG GRACE will report quarterly results on August 26, 2026 post-Market; this preview summarizes the latest forecast trends for revenue, profitability, and EPS alongside recent institutional sentiment and segment dynamics.

Market Forecast

Based on the latest forecast set, HUA HONG GRACE’s current-quarter revenue is projected at 707.49 million US dollars, implying 24.26% year-over-year growth, with forecast EPS of 0.03 and EBIT of 0.55 million US dollars; year-over-year growth rates for EPS and EBIT are 147.12% and 101.27%, respectively. The company’s margin framework from last quarter suggests a benchmark gross profit margin near 16.50% and a net profit margin near 5.38%; the market looks for incremental expansion driven by better mix and utilization, though explicit margin guidance for the new quarter is not provided.

The main business remains semiconductor products manufacturing and sales, where revenue previously tallied 717.54 million US dollars; near-term outlook centers on steady wafer demand recovery and pricing stabilization. Within this portfolio, the most promising segment remains specialty process manufacturing for differentiated products, with revenue anchored by the core semiconductor manufacturing line at 717.54 million US dollars and a year-over-year gain of 26.76% in the prior quarter, suggesting resilience into the current quarter.

Last Quarter Review

HUA HONG GRACE’s previous quarter delivered revenue of 717.54 million US dollars, gross profit margin of 16.50%, GAAP net profit attributable to the parent company of 38.64 million US dollars, net profit margin of 5.38%, and adjusted EPS of 0.02; year-over-year revenue growth reached 26.76%, with EPS up 340.00%. Quarter-on-quarter net profit growth was 84.62%, highlighting a notable rebound in profitability as demand improved and cost controls took hold.

Operationally, EBIT reached 40.93 million US dollars and tracked a 212.74% year-over-year increase, indicating operating leverage. Main business performance was led by semiconductor products manufacturing and sales at 717.54 million US dollars, underpinned by recovering foundry orders; the segment’s revenue growth of 26.76% year-over-year reflected mix improvement and stronger utilization.

Current Quarter Outlook

Core semiconductor manufacturing and sales

Management’s core revenue engine remains semiconductor product manufacturing and sales, with the forecast indicating revenue of 707.49 million US dollars and year-over-year growth of 24.26%. While the top line guide suggests a sequential normalization from last quarter’s 717.54 million US dollars, the year-over-year trajectory stays solid, implying sustained demand across specialty nodes. The prior quarter’s 16.50% gross margin provides a reference point; if utilization remains healthy and pricing doesn’t deteriorate, margins could hold near this level. The net margin benchmark of 5.38% provides limited downside protection, and any cost inflation in utilities or depreciation from capacity additions could pressure near-term profitability.

Specialty processes as the potential growth lever

The company’s differentiated specialty manufacturing remains a potential growth catalyst, supported by last quarter’s strong revenue base of 717.54 million US dollars and a 26.76% year-over-year increase. Forecasted revenue growth of 24.26% this quarter implies that specialty demand likely continues to trend upward. Mix shift toward higher-value processes can aid gross margin sustainability even if headline volumes soften modestly quarter-on-quarter. Investors should watch for commentary on capacity utilization at mature nodes and any signs of lead time normalization, which would inform how durable the specialty-led uplift will be into the next few quarters.

Key stock price swing factors

Short-term share performance is likely to respond to how reported margins compare with last quarter’s 16.50% gross margin and 5.38% net margin. A beat on gross margin would indicate better-than-expected mix and utilization, which could outweigh a slight sequential revenue dip from 717.54 million US dollars to 707.49 million US dollars. EPS sensitivity is elevated because the forecast calls for a rise to 0.03 with a 147.12% year-over-year growth assumption; any deviation here, particularly from opex or depreciation timing, could drive post-print volatility. Additionally, the EBIT guide of 0.55 million US dollars contrasts with the prior quarter’s 40.93 million US dollars, setting up a high bar for interpretation; if realized EBIT trends closer to the recent actual run-rate, consensus may need to rebase upward.

Analyst Opinions

Across the recent period, available commentary skews moderately positive, with an estimated 60% leaning bullish versus 40% cautious. Analysts highlighting recovery point to consistent year-over-year revenue growth near the mid-20% range and signs that gross margin can stabilize around the mid-teens as utilization improves. Commentary also emphasizes the potential for specialty process demand to support pricing and offset cost headwinds, which aligns with the last quarter’s EBIT outperformance versus annual comparisons. On balance, the majority view anticipates a revenue print around the current forecast, EPS trending toward 0.03, and resilience in margins near last quarter’s levels; the upside case hinges on better mix or lower-than-expected operating expense, while the bear case centers on a sharper-than-expected sequential slowdown and cost absorption from capacity investments.